Biowatch ApS Financials, key figures and credit report
Gross profit - 342.3 kDKK FY 2025 +60% vs 2024
EBIT -1 917.1 kDKK FY 2025 +11.1% vs 2024
Net debt 5 277.4 kDKK FY 2025 +17.7% vs 2024
Quick ratio 0.0 FY 2025 -0.2 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | - 411.18 | - 913.32 | - 430.39 | - 854.78 | - 342.26 |
| Employee benefit expenses | -1 317.03 | -2 481.55 | -1 306.39 | - 915.93 | - 961.28 |
| Total depreciation | - 154.56 | - 349.55 | - 386.42 | - 613.54 | |
| EBIT | -1 728.21 | -3 549.44 | -2 086.34 | -2 157.13 | -1 917.08 |
| Other financial income | 50.00 | ||||
| Other financial expenses | -2.09 | -19.68 | -66.04 | - 117.57 | - 147.53 |
| Pre-tax profit | -1 680.30 | -3 569.11 | -2 152.38 | -2 274.70 | -2 064.61 |
| Income taxes | 501.95 | 785.22 | 473.52 | - 757.75 | - 297.38 |
| Net earnings | -1 178.35 | -2 783.89 | -1 678.85 | -3 032.46 | -2 361.99 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Development expenditure | 782.77 | 1 593.21 | 1 641.76 | 2 238.59 | 1 625.05 |
| Intangible assets total | 782.77 | 1 593.21 | 1 641.76 | 2 238.59 | 1 625.05 |
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 167.12 | 41.68 | 433.93 | 52.25 | |
| Current amounts owed by group member comp. | 0.31 | 0.31 | 20.14 | ||
| Prepayments and accrued income | 4.76 | 3.03 | |||
| Current other receivables | 234.09 | 307.76 | 173.33 | 90.74 | 123.40 |
| Current deferred tax assets | 501.95 | 1 084.11 | 1 557.63 | 500.00 | |
| Short term receivables total | 736.35 | 1 559.30 | 1 792.79 | 1 029.43 | 178.68 |
| Cash and bank deposits | 2 207.34 | 372.17 | 266.78 | 9.24 | 24.36 |
| Cash and cash equivalents | 2 207.34 | 372.17 | 266.78 | 9.24 | 24.36 |
| Balance sheet total (assets) | 3 726.46 | 3 524.68 | 3 701.33 | 3 277.26 | 1 828.09 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 100.00 | 102.22 | 103.22 | 104.22 | 104.22 |
| Other reserves | 610.56 | 1 242.70 | 1 280.57 | 1 746.10 | 1 267.54 |
| Retained earnings | 2 481.00 | 2 668.29 | 845.54 | - 299.85 | -2 853.74 |
| Profit of the financial year | -1 178.35 | -2 783.89 | -1 678.85 | -3 032.46 | -2 361.99 |
| Shareholders equity total | 2 013.22 | 1 229.33 | 550.48 | -1 481.98 | -3 843.97 |
| Non-current liabilities total | |||||
| Current loans from credit institutions | 29.10 | ||||
| Current trade creditors | 310.93 | 550.92 | 403.75 | 157.29 | 322.76 |
| Current owed to participating | 26.00 | 26.00 | 26.00 | ||
| Current owed to group member | 1 278.02 | 1 589.60 | 2 613.49 | 4 438.36 | 5 275.72 |
| Other non-interest bearing current liabilities | 124.29 | 154.84 | 107.62 | 108.50 | 47.58 |
| Current liabilities total | 1 713.24 | 2 295.35 | 3 150.85 | 4 759.24 | 5 672.06 |
| Balance sheet total (liabilities) | 3 726.46 | 3 524.68 | 3 701.33 | 3 277.26 | 1 828.09 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated